Amgen Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. (AMGN) slumped 0.39% to $287.05 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.36% to 4,003.58 and the Dow Jones Industrial Average rising 1.18% to 34,098.10. Amgen Inc. closed $9.62 short of its 52-week high ($296.67), which the company reached on November 8th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.48% to $176.82, Roche Holding AG Part. Cert. fell 0.27% to $317.43, and Pfizer Inc. (PFE) rose 1.87% to $49.08. Trading volume (3.6 M) eclipsed its 50-day average volume of 2.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 22, 2022.
(END) Dow Jones Newswires
November 22, 2022 16:36 ET (21:36 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.